Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|May 19, 2009
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis CAvidan U Neumann, Stephen Pianko, Stefan Zeuzem, et al.
Drug Safety|January 8, 2020
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity MonitoringHani Shamseddeen, Eduardo Vilar-Gomez, Naga Chalasani, et al.
Journal of Hepatology|October 3, 2025
Reversal of ACLF and ALF using whole blood extracorporeal system combining HLA-depleted liver organoids with granulocyte-monocyte apheresisHitomi Yamaguchi, Yosuke Yoneyama, Kentaro Ichimura, et al.
Antiviral Therapy|February 19, 2013
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonistUri Lopatin, Grushenka Wolfgang, Daniel Tumas, et al.
Chemotherapy|June 19, 2008
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virusG Mani Subramanian, Paul A Moore, Brian B Gowen, et al.
Elife|September 4, 2019
Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypesNimisha Chaturvedi, Evguenia S Svarovskaia, Hongmei Mo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantationLewis W Teperman, Fred Poordad, Natalie Bzowej, et al.
The Journal of Infectious Diseases|January 7, 2012
Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in caninesAmisha V Barochia, Xizhong Cui, Junfeng Sun, et al.
Gastroenterology|November 23, 2013
Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infectionEdward J Gane, Catherine A Stedman, Robert H Hyland, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitisCyrielle Caussy, Jen-Chieh Chuang, Andrew Billin, et al.
Pageof 14